Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979729 · ClinicalTrials.gov registry record
Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography
A clinical trial of Breast Cancer Screening, sponsored by New Mexico Cancer Research Alliance.
- Completed
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT03979729: Completed study of Breast Cancer Screening, sponsored by New Mexico Cancer Research Alliance.
NCT03979729 is a study of Breast Cancer Screening that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 75 participants, below the 63,433-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03979729, a study of Breast Cancer Screening, has completed, sponsored by New Mexico Cancer Research Alliance.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Three-dimensional (3D) + two-dimensional (2D)- mammography may have particular value for minority, rural, and underserved women in New Mexico by decreasing recall rates and improving diagnostic sensitivity, thus alleviating some of the unique burdens associated with breast cancer screening in the multi-ethnic and underserved New Mexico patient population. Primary objective: To compare recall rates using 3D + 2D- vs. 2D- mammogram in New Mexico women undergoing screening mammogram between 2013 and 2016. Secondary objectives: Evaluate knowledge, attitudes, perceived barriers, intentions, decisional influences, and other psychosocial/cultural factors influencing breast cancer screening among medically underserved patients and assess what impact 3D + 2D-mammography might have on those perceptions; Determine primary care providers' knowledge, attitudes, beliefs, and preferences regarding 3D + 2D- vs. 2D- mammography; evaluate breast cancer detection rate and biopsy positive predictive value for screening mammograms using 3D + 2D- vs. 2D using PENRAD data; evaluate screening outcome, compliance with recall recommendations, breast cancer detection rate, positive predictive value, and demographics of interest in New Mexico women undergoing screening and offered 3-D mammography (retrospective chart review).
Primary Outcome
Compare the recall rates of New Mexico (NM) women over age 40 who underwent 3D + 2D screening mammograms vs. recall rates for women who underwent 2D- screening mammograms between 2013 and 2016 through the University of New Mexico's Department of Radiology at the University of New Mexico Hospital (UNMH) and Sandoval Regional Medical Center (SRMC). The "recall rate" is defined as the percentage (number of patients recalled per 100 patients who had mammograms) of New Mexico women undergoing screeni
Conditions Studied
Interventions
- OTHER Routine Screening Mammogram (3D + 2D)
- OTHER Routine Screening Mammogram (2D)
- OTHER No Screening Mammogram
Study Locations (1)
New Mexico
- University of New Mexico Comprehensive Cancer Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-09-22 |
| Est. Completion | 2021-06-03 |
What the finished NCT03979729 record still lists
NCT03979729 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 63,433-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Routine Screening Mammogram (3D + 2D) is the first listed.
NCT03979729 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03979729 about?
NCT03979729 is a clinical study titled "Breast Cancer Screening for Underserved Women: Comparing Outcomes and Lowering Recall Rates With 3D- vs. 2D-mammography". Three-dimensional (3D) + two-dimensional (2D)- mammography may have particular value for minority, rural, and underserved women in New Mexico by decreasing recall rates and improving diagnostic sensitivity, thus alleviating some of the unique burdens associated with breast cancer screening in the mu...
What is the current status of trial NCT03979729?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-09-22. Estimated completion is 2021-06-03.
What conditions does trial NCT03979729 study?
This clinical trial studies the following conditions: Breast Cancer Screening.
What interventions are being tested in trial NCT03979729?
The interventions under investigation include: Routine Screening Mammogram (3D + 2D) (OTHER), Routine Screening Mammogram (2D) (OTHER), No Screening Mammogram (OTHER).
Who is sponsoring clinical trial NCT03979729?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03979729 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03979729's enrollment target sits among peer trials
75 9th of 8 the lowest of 8 other Breast Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
B.Brilliant Revelation Comparision Study
RECRUITING
-
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
RECRUITING · Phase 4
-
MADRE (Mammograms Available Due to Research and Education)
RECRUITING · NA
-
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RECRUITING · NA
-
Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS
COMPLETED · NA
-
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI